NykyforukMarynaMykhaylivna . ClinicalandPathogeneticFeaturesoftheCourseandTreatmentofPsoriasisAssociatedwithMetabolicSyndrome

Українська версія

Thesis for the degree of Candidate of Sciences (CSc)

State registration number

0417U004541

Thesis Registration Form

0417U004541.pdf

Applicant for

Specialization

  • 14.01.20 - Шкірні та венеричні хвороби

07-12-2017

Specialized Academic Board

Д 26.003.02

Essay

The thesis deals with the improvement of treatment efficacy of patients with psoriasis associated with metabolic syndrome taking into account clinical and pathogenetic features of dermatosis in comorbid pathology.Іt was found that dyslipidemia, insulin resistance, blood adipocytokines levels disturbance, accompanied by subclinical inflammation development, adversely affect the course of psoriasis associated with metabolic syndrome. Patients with more components of metabolic syndrome show the higher risk of unfavorable course of psoriasis.It has been proved that the introduction of omega-3 polyunsaturated fatty acids and rosuvastatin, together with background and narrowband UVB therapy, into the combination therapy regimen for patients with psoriasis associated with metabolic syndrome increases the treatment efficacy by dynamics of рsoriasis іndeces and contributes to more prolonged remission.

Read more

Files

OKD4-174541.txt

Дисертація ВАК.docx

автореферат.doc

автореферат.doc

Similar theses

0521U101961

Yemchenko Yana O.

The study of the role of interleukin-33 and macrophages polarization in the pathogenesis of psoriasis in patients with grade I-II obesity for the development and substantiation of personalized therapy

0521U101113

Fedorych Pavlo V

Prevention of Medical and Social Consequences Caused with Genitourinary Invasions by Trichomonas and Lamblias: Diagnostics, Comprehensive Therapy, Prevention

0421U100032

Litus Iryna Oleksandrivna

Optimization of tactics for managing patients with skin tags

0520U101710

Oshyvalova Olena Oleksandrivna

Clinical and Pathogenetic, Medical and Social Rationale for Improving Secondary Prevention of Actinic Keratosis

0420U101887

Derkach Nazarii M.

Improvement of personalized diagnostics and treatment of patients with atopic dermatitis given endotoxin-mediated factors of immunopathogenesis